Affiliation:
1. National and Kapodistrian University of Athens Faculty of Medicine: Ethniko kai Kapodistriako Panepistemio Athenon Iatrike Schole
2. General Hospital of Athens Alexandra: Geniko Nosokomeio Athenon Alexandra
Abstract
Abstract
Purpose.
The objective of this retrospective study was to compare glycemic control, pregnancy outcome, as well as fetal/neonatal outcomes, between women with gestational diabetes mellitus (GDM) treated with (a) insulin detemir and (b) insulin neutral protamine Hagedorn (NPH).
Methods.
A total of 192 women with GDM were included. 98 women received detemir, while 94 women received NPH. Data regarding medical history, glycemic control, time and mode of delivery, as well as neonatal outcomes were recorded.
Results.
Baseline characteristics were comparable between the two groups. There were no differences with respect to the week of insulin initiation, total insulin dose, duration of insulin therapy, daily insulin dose/weight in early and late pregnancy, as well as the number of insulin injections per day. Maternal overall weight gain during pregnancy, and weight gain per week did not differ either. The detemir group had slightly lower HbA1c level at the end of gestation [median: Det 5.2% (33 mmol/mol) vs NPH 5.4% (36 mmol/mol), p = 0.035). There were no hypoglycemias or allergic reactions in both groups. There were also no differences regarding neonatal outcomes
Conclusion.
The use of insulin detemir for glucose control was found to be equally effective and safe compared with NPH.
Publisher
Research Square Platform LLC
Reference33 articles.
1. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Groupthresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia;Ferrara A;Diabetologia.,2007
2. L. Hartling, D.M. Dryden, A. Guthrie, M. Muise, B. Vandermeer, L. Donovan. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann. Intern. Med. 2013 Jul 16;159(2):123–129. https://doi.org/10.7326/0003-4819-159-2-201307160-00661
3. Hyperglycemia and adverse pregnancy outcomes;Metzger BE;N Engl J Med. 2008 May
4. C.A.1 Crowther, J.E. Hiller, J.R. Moss, A.J. McPhee, W.S. Jeffries, J.S. Robinson; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005 Jun 16;352(24):2477-86. https://doi.org/10.1056/NEJMoa042973
5. M.B.1 Landon, C.Y. Spong, E. Thom, M.W. Carpenter, S.M. Ramin, B. Casey et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009 Oct 1;361(14):1339-48. https://doi.org/10.1056/NEJMoa0902430